CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 136 filers reported holding CONSTELLATION PHARMCETICLS I in Q1 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $28,799,000 | +12207.3% | 852,040 | +8420.4% | 0.02% | – |
Q1 2021 | $234,000 | -97.5% | 10,000 | -96.9% | 0.00% | -100.0% |
Q4 2020 | $9,293,000 | -0.1% | 322,684 | -29.7% | 0.01% | -36.4% |
Q3 2020 | $9,305,000 | +38.8% | 459,286 | +105.9% | 0.01% | +22.2% |
Q2 2020 | $6,704,000 | -53.4% | 223,101 | -51.2% | 0.01% | -71.9% |
Q1 2020 | $14,381,000 | -47.3% | 457,568 | -20.9% | 0.03% | -8.6% |
Q4 2019 | $27,267,000 | +16941.9% | 578,799 | +2332.2% | 0.04% | – |
Q3 2018 | $160,000 | – | 23,797 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP, LLC | 3,034,083 | $41,112,000 | 40.71% |
Svennilson Peter | 4,677,939 | $63,386,000 | 33.76% |
VHCP Management II, LLC | 726,677 | $9,846,000 | 2.88% |
Casdin Capital, LLC | 1,556,999 | $21,097,000 | 2.32% |
Cormorant Asset Management, LP | 1,271,687 | $17,231,000 | 1.16% |
VHCP Management III, LLC | 66,667 | $903,000 | 0.53% |
Hillhouse Capital Management | 317,921 | $4,308,000 | 0.18% |
Orbimed Advisors | 835,842 | $11,326,000 | 0.18% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 66,186 | $897,000 | 0.13% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 253,400 | $3,434,000 | 0.13% |